(Q61956142)

English

Long Term Safety and Efficacy of Biphasic Insulin Aspart 30 in Type 2 Diabetes

clinical trial

Statements

An Open Label, Non Comparative, Multicentre Extension Trial to Assess the Long Term Safety and Efficacy of Biphasic Insulin Aspart 30 in Subjects With Type 2 Diabetes Who Have Completed BIAsp-1234 (English)
0 references
0 references
0 references
8 January 2001
0 references
22 October 2004
0 references
89
0 references
18 year
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit